Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study.
Marina PeballKlaus SeppiFlorian KrismerHans-Günther KnausSabine SpielbergerBeatrice HeimPhilipp EllmererMario WerkmannWerner PoeweAtbin DjamshidianPublished in: Movement disorders clinical practice (2022)
This post-hoc analysis of the NMS-Nab trial suggests that nabilone has beneficial effects on sleep outcomes in PD patients experiencing sleep problems at baseline.The original trial was registered with ClinicalTrials.gov (NCT03769896, https://clinicaltrials.gov/ct2/show/NCT03769896) and EudraCT (2017-000192-86).
Keyphrases
- sleep quality
- end stage renal disease
- physical activity
- study protocol
- phase iii
- clinical trial
- ejection fraction
- chronic kidney disease
- phase ii
- newly diagnosed
- mental health
- advanced non small cell lung cancer
- computed tomography
- magnetic resonance imaging
- peritoneal dialysis
- type diabetes
- contrast enhanced
- patient reported outcomes
- open label
- image quality
- positron emission tomography
- patient reported